Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > CG Oncology IPO Today

<< Previous

Bullboard Posts

Next >>

Comment by stocksnbonds458on Jan 26, 2024 3:17pm

169 Views

Post# 35847696

RE:RE:RE:RE:RE:CG Oncology IPO Today

Skys, 1 trillion is only around $ 3200.00 per share (assuming 300M out fully diluted). We can do better lol. When I multiply that figure by the number of shares I own, my calculator returns an error as it can't fit that may zeros in. 

<< Previous

Bullboard Posts

Next >>

Three micro-cap value stocks trading at peak pessimism